Yoko Hirai Selected Research

arbekacin

1/2018

In vitro and in vivo antimicrobial activity of TS2037, a novel aminoglycoside antibiotic.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoko Hirai Research Topics

Disease

2	Infections 01/2021 - 01/2018
2	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 09/2018
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2017 - 06/2016
1	Abscess 01/2021
1	Neoplasms (Cancer) 01/2019
1	Neuroendocrine Carcinoma 09/2018
1	Pseudomonas Infections 01/2018
1	Endocarditis 08/2005

Drug/Important Bio-Agent (IBA)

2	Lincomycin (Lincocin)FDA Link 01/2021 - 01/2017
2	Linezolid (Zyvox)FDA Link 01/2021 - 01/2018
2	Clindamycin (Cleocin)FDA LinkGeneric 01/2021 - 06/2016
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2019 - 09/2018
2	Vancomycin FDA LinkGeneric 01/2018 - 08/2005
1	alpha-methylacyl-CoA racemaseIBA 09/2018
1	ts2037IBA 01/2018
1	arbekacinIBA 01/2018
1	AminoglycosidesIBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	Carbapenems (Carbapenem Antibiotics)IBA 08/2005
1	ME1036IBA 08/2005
1	Therapeutic UsesIBA 08/2005